Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis.

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis. Neurology. 1998 Jul; 51(1):239-45.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.